Skip to content

Bioalmanac

Adamax

N-Acetyl Semax Amidate variant · Adamax peptide

Preclinical

Status reviewed 18 Aug 2026

A Semax derivative sold with adamantane-related branding. The least documented compound on this site, and that is saying something.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C. Nasal solutions are handled more than injectables and are correspondingly easier to contaminate.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Commonly described community protocol200–500 mcgOnce dailyCommunity practice

When to stop

  • Any new neurological or psychiatric symptom.
  • Sleep disturbance that does not settle.
  • Nasal pain, bleeding or discharge.
  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.

Not approved anywhere and not studied anywhere. Sold as a research chemical with no published characterisation.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/adamax

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.